File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: ω-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS

Titleω-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS
Authors
KeywordsHIF-1a
iNOS
M2 macrophage polarization
Myocardial ischemia-reperfusion injury
PKM2
ω-Alkynyl arachidonic acid
Issue Date2017
Citation
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017, v. 1862, p. 1595-1605 How to Cite?
AbstractMacrophage polarization determines the timing for the switch from the inflammation phase to the inflammation resolution phase after acute myocardial infarction. The aim of the present study was to investigate whether ω-alkynyl arachidonic acid could mitigate the inflammatory lipid mediators in the regulation of macrophage phenotypes and functions with a special regard to myocardial infarction. We initially discovered that ω-alkynyl arachidonic acid selectively suppressed the up-regulation of inducible nitric oxide synthase (iNOS) over cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages. ω-Alkynyl arachidonic acid also reduced the expression of macrophage M1 biomarkers (e.g., TNF-α, CXCL10, iNOS and IL-6) but increased the expression of macrophage M2 biomarkers (e.g., IL-10 and arginase-1) in LPS-stimulated macrophages. Moreover, ω-alkynyl arachidonic acid markedly enhanced the phagocytotic activity of macrophages against fluorescently-labeled beads or apoptotic H9c2 cardiac cells. We further investigated the in vivo cardioprotective activities of ω-alkynyl arachidonic acid in a mouse model of myocardial infarction. ω-Alkynyl arachidonic acid indeed reduced infarct size, cardiac damage and the leakage of myocardial enzymes CK-MB. Mechanistic studies revealed that ω-alkynyl arachidonic acid suppressed the overexpression and nuclear translocation of glycolytic enzyme PKM2 in LPS-stimulated macrophages. Furthermore, co-immunoprecipitation assay suggested that ω-alkynyl arachidonic acid disrupted the interaction between PKM2 and HIF-1α. Consequently, ω-alkynyl arachidonic acid diminished HIF-1α binding to the HRE sequence in iNOS promoter in response to LPS stimulation. Collectively, ω-alkynyl arachidonic acid may promote the anti-inflammatory M2 polarization of macrophages in acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS.
Persistent Identifierhttp://hdl.handle.net/10722/250257
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCHENG, Y-
dc.contributor.authorFeng, Y-
dc.contributor.authorXia, Z-
dc.contributor.authorLi, XC-
dc.contributor.authorRong, J-
dc.date.accessioned2017-12-20T09:23:06Z-
dc.date.available2017-12-20T09:23:06Z-
dc.date.issued2017-
dc.identifier.citationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017, v. 1862, p. 1595-1605-
dc.identifier.urihttp://hdl.handle.net/10722/250257-
dc.description.abstractMacrophage polarization determines the timing for the switch from the inflammation phase to the inflammation resolution phase after acute myocardial infarction. The aim of the present study was to investigate whether ω-alkynyl arachidonic acid could mitigate the inflammatory lipid mediators in the regulation of macrophage phenotypes and functions with a special regard to myocardial infarction. We initially discovered that ω-alkynyl arachidonic acid selectively suppressed the up-regulation of inducible nitric oxide synthase (iNOS) over cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages. ω-Alkynyl arachidonic acid also reduced the expression of macrophage M1 biomarkers (e.g., TNF-α, CXCL10, iNOS and IL-6) but increased the expression of macrophage M2 biomarkers (e.g., IL-10 and arginase-1) in LPS-stimulated macrophages. Moreover, ω-alkynyl arachidonic acid markedly enhanced the phagocytotic activity of macrophages against fluorescently-labeled beads or apoptotic H9c2 cardiac cells. We further investigated the in vivo cardioprotective activities of ω-alkynyl arachidonic acid in a mouse model of myocardial infarction. ω-Alkynyl arachidonic acid indeed reduced infarct size, cardiac damage and the leakage of myocardial enzymes CK-MB. Mechanistic studies revealed that ω-alkynyl arachidonic acid suppressed the overexpression and nuclear translocation of glycolytic enzyme PKM2 in LPS-stimulated macrophages. Furthermore, co-immunoprecipitation assay suggested that ω-alkynyl arachidonic acid disrupted the interaction between PKM2 and HIF-1α. Consequently, ω-alkynyl arachidonic acid diminished HIF-1α binding to the HRE sequence in iNOS promoter in response to LPS stimulation. Collectively, ω-alkynyl arachidonic acid may promote the anti-inflammatory M2 polarization of macrophages in acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS.-
dc.languageeng-
dc.relation.ispartofBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids-
dc.subjectHIF-1a-
dc.subjectiNOS-
dc.subjectM2 macrophage polarization-
dc.subjectMyocardial ischemia-reperfusion injury-
dc.subjectPKM2-
dc.subjectω-Alkynyl arachidonic acid-
dc.titleω-Alkynyl arachidonic acid promotes anti-inflammatory macrophage M2 polarization against acute myocardial infarction via regulating the cross-talk between PKM2, HIF-1α and iNOS-
dc.typeArticle-
dc.identifier.emailFeng, Y: yfeng@hku.hk-
dc.identifier.emailXia, Z: zyxia@hkucc.hku.hk-
dc.identifier.emailLi, XC: xuechenl@hku.hk-
dc.identifier.emailRong, J: jrong@hku.hk-
dc.identifier.authorityFeng, Y=rp00466-
dc.identifier.authorityXia, Z=rp00532-
dc.identifier.authorityLi, XC=rp00742-
dc.identifier.authorityRong, J=rp00515-
dc.identifier.doi10.1016/j.bbalip.2017.09.009-
dc.identifier.scopuseid_2-s2.0-85030315099-
dc.identifier.hkuros283830-
dc.identifier.volume1862-
dc.identifier.spage1595-
dc.identifier.epage1605-
dc.identifier.isiWOS:000414815300012-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats